MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹8,749 Cr | ₹7,782 Cr | ₹621 Cr | ₹58,719 Cr | ₹4,980 Cr |
What is the latest Revenue of MANKIND PHARMA ?
Year | Revenue |
---|---|
Mar2024 | ₹8,749 Cr |
Mar2023 | ₹7,782 Cr |
Mar2022 | ₹621 Cr |
Mar2021 | ₹58,719 Cr |
Mar2020 | ₹4,980 Cr |
How is Revenue of MANKIND PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹8,749 Cr | 12.44 | |
Mar2023 | ₹7,782 Cr | 1,152.18 | |
Mar2022 | ₹621 Cr | -98.94 | |
Mar2021 | ₹58,719 Cr | 1,079.10 | |
Mar2020 | ₹4,980 Cr | - |
Compare Revenue of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹102,240.6 Cr | -2.1% | -0.6% | 33.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -2.1% |
-0.6% |
33.1% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses